Anika Therapeutics reported $146K in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Agenus AGEN:US $ 2.83M 0.16M
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Anika Therapeutics ANIK:US $ 0.15M 0M
Arrowhead Research ARWR:US $ 198K 0
Chemocentryx CCXI:US $ 0.07M 0M
Clovis Oncology CLVS:US $ 0.14M 0M
Enanta Pharmaceuticals ENTA:US $ 0.21M 0M
Halozyme Therapeutics HALO:US $ 0.14M 0M
Heron Therapeutics HRTX:US $ 1.02M 0M
Insmed INSM:US $ 1.2M 6K
Integra Lifesciences IART:US $ 0.9M 0M
Intrexon XON:US $ 0M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Ligand Pharmaceuticals LGND:US $ 0.02M 0M
Macrogenics MGNX:US $ 0.62M 0M
Merit Medical Systems MMSI:US $ 651.93M 5.56M
Peregrine Pharmaceuticals PPHM:US $ 0.06M 0M
Rigel Pharmaceuticals RIGL:US $ 0.17M 0M
Sangamo Biosciences SGMO:US $ 1.53M 0.07M
Surmodics SRDX:US $ 0.7M 0M
Veracyte VCYT:US $ 0.07M 0M
Xencor XNCR:US $ 0.6M 0M
Zimmer Biomet Holdings Inc ZBH:US $ 3.1M 0